CN Patent

CN116440074B — 一种氯化钾口服制剂及其制备方法

Assigned to Zhejiang Gaozhi Pharmaceutical Technology Co ltd · Expires 2024-02-20 · 2y expired

What this patent protects

本发明涉及医药制剂技术领域，具体涉及一种氯化钾口服制剂及其制备方法。所述氯化钾口服制剂包括氯化钾、抑菌剂、pH调节剂、矫味剂、增稠剂、甜味剂和香精，所述pH调节剂为枸橼酸和枸橼酸钠的混合物，两者质量比为2:1～1:3，本发明具有口感好、无后味、稳定性高的优点。

USPTO Abstract

本发明涉及医药制剂技术领域，具体涉及一种氯化钾口服制剂及其制备方法。所述氯化钾口服制剂包括氯化钾、抑菌剂、pH调节剂、矫味剂、增稠剂、甜味剂和香精，所述pH调节剂为枸橼酸和枸橼酸钠的混合物，两者质量比为2:1～1:3，本发明具有口感好、无后味、稳定性高的优点。

Drugs covered by this patent

Patent Metadata

Patent number: CN116440074B
Jurisdiction: CN
Classification: —
Expires: 2024-02-20
Drug substance claim: No
Drug product claim: No
Assignee: Zhejiang Gaozhi Pharmaceutical Technology Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.